reviewTop 1% cited
Albumin as a versatile platform for drug half-life extension
Biochimica et Biophysica Acta (BBA) - General Subjects · 2013 · Vol. 1830(12) · pp. 5526–5534
Darrell Sleep✉(Novozymes (United Kingdom))Jason Cameron(Novozymes (United Kingdom))Leslie Evans(Novozymes (United Kingdom))
Monoclonal and Polyclonal Antibodies ResearchChronic Lymphocytic Leukemia ResearchPharmacogenetics and Drug MetabolismAlbuminCirculatory systemPharmacokineticsSerum albuminDrugPharmacologyChemistryMedicineBiochemistryInternal medicine
MeSH terms
AnimalsHalf-LifeHumansImmunoglobulin GPharmacokineticsReceptors, FcSerum Albumin
Citations
467
FWCI
24.89
field-weighted impact
References
117
Percentile
100%
vs. same field & year
Citations per year
Cited by
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Nature Reviews Drug Discovery · 2014 · 1,597 citations
The Current State of Peptide Drug Discovery: Back to the Future?
Journal of Medicinal Chemistry · 2017 · 1,075 citations
References
Impact of albumin on drug delivery — New applications on the horizon
Journal of Controlled Release · 2011 · 811 citations
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Journal of Controlled Release · 2008 · 2,096 citations
FcRn: the neonatal Fc receptor comes of age
Nature reviews. Immunology · 2007 · 2,228 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.